CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 8-K Event Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- 4 Insider Changes in Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- 8-K Event Delisting notice · Other events
- 4 Open-market buy CEO & President bought 107 shares at $7.70 ($824)
- 4 Open-market buy CEO & President bought 103 shares at $8.70 ($896)
Page 5 of 82 · 1,636 filings